Biocept, Inc. (NASDAQ:BIOC) gained $0.03 before the end of the regular trading session on Wednesday, hitting $0.25. Turning now to volume, 3.04 million shares of this company’s stock were traded. Biocept, Inc. (NASDAQ:BIOC) has seen its stock have a 1-year low price of $0.17 as well as a 1-year high price of $1.64. Currently, this company’s debt-to-equity ratio is 0.27, its quick ratio is 2.30, its current ratio is 2.40. This organization, at the moment, a beta score of 1.90, a market cap of $18.34M.
Chardan Capital Markets Reiterated shares of Biocept, Inc. (NASDAQ:BIOC) to a Buy rating in a report posted on Tuesday, November 14th, 2017. At the present, they have a price target for the Medical Laboratories & Research set at $1.50. Several additional equities analysts have also published recent reports on BIOC stock. Chardan Capital Markets, for example, Initiated Biocept, Inc. to Buy in a report that was made public on Friday, June 2nd, 2017. ROTH Capital Initiated a $1.20 price target on Biocept, Inc. in a report from Monday, June 6th, 2016, while giving the stock to a Buy rating. In a report sent out on Wednesday, August 19th, 2015, H.C. Wainwright Initiated the stock rating on Biocept, Inc. to a Buy. Lastly, a Buy rating on shares of Biocept, Inc. was Initiated by Aegis Capital, which also set a $16 price target on the company’s stock. In total, 1 Wall Street analysts have given this stock a hold rating, with 1 analysts rating it as a strong buy.
There is a technical analysis indicator called the Relative Strength Index, or RSI, and analysts use it to measure momentum within a range of 0 to 100. When a stock’s RSI falls under 30, it is considered to be oversold. For Biocept, Inc., specifically, the RSI metric has reached 65.17. Biocept, Inc. (NASDAQ:BIOC) has lost -29.94% in value over the last three months, and -63.97% over the last six-month period. Over the last full year, the stock price has lost -81.46%.
Let’s move onto another metric: volatility. This term refers to the price range of a stock where a day trader makes his or her trades, which is essentially a measure of a specific stock’s predictably price range per day. Higher levels of volatility indicate higher profits or losses. After recently verifying the number, Biocept, Inc. (NASDAQ:BIOC) stock has a volatility measurement of 10.49% for the week, with 10.06% volatility as observed from the past 30 days. The public company has 72.73M shares outstanding currently, as well as a market cap of $18.34M. This stock’s distance from its 20-day simple moving average is 22.92%, based on a recent bid, while its distance from the 50-day simple moving average is currently 13.32%. Meanwhile, it has a distance of -59.21% from the 200-day simple moving average. Today, this organization is sitting -84.62% away from its 52-week high price and 48.35% away from its 52-week low price.
There is another metric that stock traders who are more detail-oriented will focus on: the Williams Percent Range or Willams %R. This metric is a popular technical indicator first created by Larry Williams, its founder, and it enables traders to identify overbought and oversold stock territory. Seasoned stock traders will usually use the Williams %R metric in combination with other trend indicators to enable the locating of possible turning points in a specific stock’s price path. Biocept, Inc. (NASDAQ:BIOC)’s Williams Percent Range, or 14-day Williams %R, is sitting at 8.89 at the time of writing. Generally speaking, if the indicator rises above -20, the shares may be overbought. On the flip side, if the indicator goes below -80, it may mean that the stock has crossed over into oversold territory.
Oftentimes, investors will keep tables on the most recent stock price support and resistance levels. When we say support, we mean the lower “floor” level where a company’s stock may bounce back after falling. If the stock’s price can breach the first support level, then the general investor attention might transition to the second level. Resistance, on the other hand, is the opposite. While a certain stock increases in value, it might see a plunge as it reaches a specific level of resistance on the higher end.After a recent examination, this company’s shares’ first resistance level is sitting at 0.27. Meanwhile, investors are looking out for the first support level, which is 0.22.